Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LVD Biotech is a specialized medical device company based in Shanghai that focuses on the research, development, and production of cardiovascular interventional therapies. As a subsidiary of Lepu Medical, the company is a leader in the Chinese market for drug-eluting stents, most notably through its BuMA stent series. The BuMA stent features a proprietary electro-grafting base layer and a biodegradable polymer coating designed to optimize drug release and promote faster vessel healing. LVD Biotech's portfolio also includes advanced balloon catheters and delivery systems used in percutaneous coronary interventions. The company's innovations aim to reduce long-term complications such as late stent thrombosis in patients with coronary artery disease. Its products are widely utilized in hospitals across China and have received CE mark for distribution in international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LVD.